Mrv0541 09131211492D 16 17 0 0 0 0 999 V2000 5.0013 5.9411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 3.0536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7309 2.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5559 2.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 5.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 4.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8579 5.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 4.2911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 3.4661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 5.9411 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 1.4760 2.9812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8109 2.9812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 5.9411 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 4.2868 4.7036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 4.2911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5724 3.4661 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4 3 1 0 0 0 0 5 1 1 0 0 0 0 7 6 2 0 0 0 0 8 6 1 0 0 0 0 10 7 1 0 0 0 0 11 3 1 0 0 0 0 11 9 2 0 0 0 0 12 4 1 0 0 0 0 12 9 1 0 0 0 0 13 5 2 0 0 0 0 13 7 1 0 0 0 0 14 5 1 0 0 0 0 14 8 2 0 0 0 0 15 6 1 0 0 0 0 15 9 1 0 0 0 0 16 2 1 0 0 0 0 16 8 1 0 0 0 0 M END > DB09242 > drugbank > COC1=NC(C)=NC(Cl)=C1NC1=NCCN1 > InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15) > WPNJAUFVNXKLIM-UHFFFAOYSA-N > C9H12ClN5O > 241.677 > 241.073037738 > 6 > 28 > 0.6463602892733249 > 23.570104980815643 > 1 > 2 > 0 > 1 > 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine > 1.01 > 1.5387770663333333 > -3.33 > 0 > 1 > 2 > 1 > 7.2619138667058465 > 71.43 > 63.41069999999999 > 2 > 1 > 1.14e-01 g/l > tetrahydrofolic acid > 0 > DB09242 > approved; investigational > Moxonidine > (2R,4R)-1-[(2S)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8- quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid; Moxonidina; Moxonidine; Moxonidinum > Cynt > Moxonidine hydrochloride $$$$